High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.

Three months of weekly rifapentine plus isoniazid (3HP) is a short course regimen for latent tuberculosis infection treatment with satisfied safety and efficacy. However, research on its use in children is limited. In this study, we evaluated the completion rate and safety of the 3HP regimen among c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heng Yang, Yang Yang, Zhi-Dong Hu, Lu Xia, Xu-Hui Liu, Xin Yu, Jia-Ye Ma, Tao Li, Shui-Hua Lu
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d870e0a6b3914df782c79e3639dbd6f6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d870e0a6b3914df782c79e3639dbd6f6
record_format dspace
spelling oai:doaj.org-article:d870e0a6b3914df782c79e3639dbd6f62021-12-02T20:10:44ZHigh rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.1932-620310.1371/journal.pone.0253159https://doaj.org/article/d870e0a6b3914df782c79e3639dbd6f62021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0253159https://doaj.org/toc/1932-6203Three months of weekly rifapentine plus isoniazid (3HP) is a short course regimen for latent tuberculosis infection treatment with satisfied safety and efficacy. However, research on its use in children is limited. In this study, we evaluated the completion rate and safety of the 3HP regimen among children in China. Participants aged 1-14 years receiving 3HP for TB prevention at Shanghai Public Health Clinical Center were followed from December 2019 to November 2020 to evaluate the safety and completion rate of the treatment. Thirty-one children were eligible for inclusion, but five were excluded from the analysis (three were treated with a lower than recommended dose, and two were lost to follow-up). Of the 26 children included in the analysis, the treatment completion rate was 100%. Adverse drug reactions (ADRs) were reported in 38.5% (10/26) of the patients. The most common ADRs were gastrointestinal symptoms (19.2%,5/26), and all ADRs were rated as Grade 1. The 3HP regimen has a high completion rate, and it seems well tolerated in our study population. However, further randomized controlled clinical trial with larger sample size are warranted.Heng YangYang YangZhi-Dong HuLu XiaXu-Hui LiuXin YuJia-Ye MaTao LiShui-Hua LuPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0253159 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Heng Yang
Yang Yang
Zhi-Dong Hu
Lu Xia
Xu-Hui Liu
Xin Yu
Jia-Ye Ma
Tao Li
Shui-Hua Lu
High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
description Three months of weekly rifapentine plus isoniazid (3HP) is a short course regimen for latent tuberculosis infection treatment with satisfied safety and efficacy. However, research on its use in children is limited. In this study, we evaluated the completion rate and safety of the 3HP regimen among children in China. Participants aged 1-14 years receiving 3HP for TB prevention at Shanghai Public Health Clinical Center were followed from December 2019 to November 2020 to evaluate the safety and completion rate of the treatment. Thirty-one children were eligible for inclusion, but five were excluded from the analysis (three were treated with a lower than recommended dose, and two were lost to follow-up). Of the 26 children included in the analysis, the treatment completion rate was 100%. Adverse drug reactions (ADRs) were reported in 38.5% (10/26) of the patients. The most common ADRs were gastrointestinal symptoms (19.2%,5/26), and all ADRs were rated as Grade 1. The 3HP regimen has a high completion rate, and it seems well tolerated in our study population. However, further randomized controlled clinical trial with larger sample size are warranted.
format article
author Heng Yang
Yang Yang
Zhi-Dong Hu
Lu Xia
Xu-Hui Liu
Xin Yu
Jia-Ye Ma
Tao Li
Shui-Hua Lu
author_facet Heng Yang
Yang Yang
Zhi-Dong Hu
Lu Xia
Xu-Hui Liu
Xin Yu
Jia-Ye Ma
Tao Li
Shui-Hua Lu
author_sort Heng Yang
title High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
title_short High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
title_full High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
title_fullStr High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
title_full_unstemmed High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study.
title_sort high rate of completion for weekly rifapentine plus isoniazid treatment in chinese children with latent tuberculosis infection-a single center study.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/d870e0a6b3914df782c79e3639dbd6f6
work_keys_str_mv AT hengyang highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy
AT yangyang highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy
AT zhidonghu highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy
AT luxia highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy
AT xuhuiliu highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy
AT xinyu highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy
AT jiayema highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy
AT taoli highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy
AT shuihualu highrateofcompletionforweeklyrifapentineplusisoniazidtreatmentinchinesechildrenwithlatenttuberculosisinfectionasinglecenterstudy
_version_ 1718374975646203904